COMMUNIQUÉS West-GlobeNewswire

Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
07/01/2026
BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that [...]
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
07/01/2026
FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) [...]
BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes
07/01/2026
Decision ensures continued patient access to VENDAJE ® and VENDAJE AC ® POMPANO BEACH, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development [...]
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors
07/01/2026
Mr. Dewhurst Brings Over 30 Years of Life Sciences and M&A Experience to the Board, Aligning with the Company’s Strategic Long-Term Goals for Growth and Expansion LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Turn [...]
Abivax Provides 2026 Corporate Outlook
07/01/2026
Abivax Provides 2026 Corporate Outlook New market insights indicate significant future expansion of the ulcerative colitis (UC) market, with obefazimod well positioned to become a future market leader in the IBD space [...]
Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
07/01/2026
SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation [...]
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
07/01/2026
AUDUBON, Pa., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year [...]
Onco360® Has Partnered with Rigel Pharmaceuticals to Add Three Therapies to Its Limited Distribution Portfolio
07/01/2026
LOUISVILLE, Ky., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent specialty pharmacy, has been chosen by Rigel Pharmaceuticals as limited distribution specialty pharmacy partner for [...]
Jasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth
07/01/2026
Thomas Wiggans appointed Executive Chairperson Jasper to host an investor webinar on January 8 th at 8:00am ET to present updated data from the BEACON study in CSU and the open-label extension study in CSU and CIndU [...]
Park Dental Partners Completes Acquisitions of Two Practices - Enters Phoenix Market and Expands Twin Cities Presence
07/01/2026
MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) (the Company), a leading dental resource organization, announced the completion of two general dentistry practice acquisitions on [...]
Built In Honors Xealth as a Top 10 Best Startup to Work for in Seattle
07/01/2026
Xealth Earns High Ranking on Built In’s Esteemed 2026 Best Places to Work Awards SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Xealth , the leading digital health platform that brings diverse digital tools and care [...]
MESA LABS DECLARES QUARTERLY DIVIDEND
07/01/2026
LAKEWOOD, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0 [...]
Correction: Transactions of Managers and Closely Associated Persons
07/01/2026
Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons. ATP Holdings ehf. announced two [...]
LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates
07/01/2026
Launched VIZZ™ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product availability in mid-November 2025 Achieved approximately $1.6 million in net product revenue with [...]
Range Impact Announces Two Major Land Acquisitions in Kentucky and Sale of Abandoned Mine Land Services Business
07/01/2026
CLEVELAND, OHIO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing distressed coal mine properties [...]
Neocis Surpasses 100,000 Robotic Osteotomies with the Yomi Platform
07/01/2026
Landmark milestone demonstrates proven robotic adoption as the next generation Yomi S completes the first real world cases MIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Neocis, the market leader behind the Yomi® robotic [...]
National Institutes of Health Awards $1.54M Grant To Scottish Rite for Children for Rare Diseases Research
07/01/2026
Promising Hydrogel Could Help Kids Walk Again and Adults Avoid Invasive Surgery Dallas, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Every year, thousands of children and adults face the crippling effects of osteonecrosis. Now, [...]
GENFIT annonce son calendrier financier pour 2026
07/01/2026
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 7 janvier 2026 – GENFIT (Euronext : GNFT) , société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des [...]
GENFIT Announces 2026 Financial Calendar
07/01/2026
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 7, 2026 - GENFIT (Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare [...]

Pages